See more : Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Meihua International Medical Technologies Co., Ltd. (MHUA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Meihua International Medical Technologies Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Joshin Denki Co., Ltd. (8173.T) Income Statement Analysis – Financial Results
- Optiscan Imaging Limited (OIL.AX) Income Statement Analysis – Financial Results
- Pembina Pipeline Corporation (PBA) Income Statement Analysis – Financial Results
- Peña Verde, S.A.B. (PV.MX) Income Statement Analysis – Financial Results
- ARS Pharmaceuticals, Inc. (SPRY) Income Statement Analysis – Financial Results
Meihua International Medical Technologies Co., Ltd. (MHUA)
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 97.10M | 103.35M | 104.04M | 89.06M | 79.63M | 75.71M |
Cost of Revenue | 64.00M | 65.25M | 64.23M | 51.90M | 47.42M | 43.82M |
Gross Profit | 33.10M | 38.10M | 39.81M | 37.16M | 32.21M | 31.89M |
Gross Profit Ratio | 34.08% | 36.86% | 38.26% | 41.72% | 40.45% | 42.12% |
Research & Development | 2.75M | 2.96M | 2.73M | 2.49M | 3.21M | 2.87M |
General & Administrative | 7.82M | 13.04M | 5.32M | 3.71M | 3.28M | 4.16M |
Selling & Marketing | 5.15M | 5.64M | 6.46M | 6.62M | 5.41M | 5.67M |
SG&A | 15.67M | 18.68M | 11.78M | 10.34M | 8.68M | 9.85M |
Other Expenses | 1.00 | 898.66K | -50.44K | 864.79K | 926.20K | 0.00 |
Operating Expenses | 18.42M | 22.54M | 14.50M | 13.69M | 12.82M | 13.10M |
Cost & Expenses | 82.42M | 87.79M | 78.74M | 65.59M | 60.24M | 56.92M |
Interest Income | 873.44K | 63.73K | 23.86K | 36.58K | 48.84K | 77.42K |
Interest Expense | 250.78K | 194.67K | 180.74K | 137.16K | 97.79K | 0.00 |
Depreciation & Amortization | 470.99K | 563.46K | 622.47K | 523.43K | 509.22K | 567.77K |
EBITDA | 15.77M | 16.12M | 26.88M | 23.99M | 19.90M | 19.74M |
EBITDA Ratio | 16.24% | 15.61% | 24.89% | 26.95% | 25.05% | 26.08% |
Operating Income | 14.67M | 15.57M | 25.30M | 23.47M | 19.39M | 19.18M |
Operating Income Ratio | 15.11% | 15.06% | 24.32% | 26.35% | 24.35% | 25.33% |
Total Other Income/Expenses | 373.84K | 89.29K | -32.91K | 267.35K | -137.69K | -465.98K |
Income Before Tax | 15.05M | 10.89M | 25.27M | 23.73M | 19.25M | 18.71M |
Income Before Tax Ratio | 15.50% | 10.54% | 24.29% | 26.65% | 24.18% | 24.72% |
Income Tax Expense | 3.46M | 4.71M | 5.28M | 4.69M | 3.82M | 3.23M |
Net Income | 11.63M | 6.24M | 20.95M | 19.05M | 15.43M | 15.48M |
Net Income Ratio | 11.97% | 6.04% | 20.14% | 21.38% | 19.38% | 20.44% |
EPS | 0.49 | 0.27 | 0.89 | 0.79 | 0.64 | 0.77 |
EPS Diluted | 0.49 | 0.27 | 0.89 | 0.79 | 0.64 | 0.77 |
Weighted Avg Shares Out | 23.94M | 23.41M | 23.60M | 24.14M | 24.14M | 20.00M |
Weighted Avg Shares Out (Dil) | 23.94M | 23.41M | 23.60M | 24.14M | 24.14M | 20.00M |
Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City
Meihua International Medical Technologies Co., Ltd.'s Subsidiary Officially Commences Construction of Comprehensive Medical Industrial Park in Hainan Free Trade Port Boao Hope City
Meihua International Medical Technologies Co., Ltd. Reports Unaudited 2023 First Half Financial Results
Tech Stocks Are Surging
Why Shares of Meihua International Soared This Week
Why Shares of Zhihu, TH International, and Meihua International Medical Tech Are Blasting Higher This Week
Investors May Want to Follow Progress of VC-Backed Medtechs
U.S. IPO Weekly Recap: The IPO Market's Micro-Cap Run Continues With 2 Small Healthcare Deals
Investors Give, Then Take Away, In Meihua's New York Trading Debut
Source: https://incomestatements.info
Category: Stock Reports